-
FDA Wants New Safety Studies For Adderall, Other ADHD Drugs
Reports Of Serious Adverse Events Involving Sudden Death, Heart Attack, and Stroke Reports of sudden deaths, heart attacks, and strokes in both children and adults taking drugs to treat attention deficit hyperactivity disorder (ADHD)…
-
January 2006 FDA “Patient Safety News” Videos For Doctors Online
Edition Covers Ortho Evra, Cymbalta, Asthma Medications and More The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for doctors and other health care professionals. Generally, this…
-
The Negative Affects of Clinical Trials Funded By Drug Companies
How Did We Get Into This Situation, And How Can We Get Out: Two Recent Editorials In December 2005 The New England Journal of Medicine (NEJM) announced that it had learned about "inaccuracies and…
-
Original “First” Vioxx Trial Will Be Nation’s Fourth: Garza v. Merck, et.al.
Next Vioxx Case Goes to Court Late January 2006 In Starr County, Texas The nation’s fourth Vioxx trial against Merck & Co. concerning its recalled painkiller Vioxx is reportedly set to begin, with jury…
-
Global Vioxx Settlement “Unacceptable” To Merck CEO Richard Clark
With Three Vioxx Trials Under Its Belt, Merck Sticks To Its Guns On January 3, 2006 Merck & Co.’s Chief Executive Officer Richard Clark told a Morgan Stanley pharmaceutical conference audience that Merck will…
-
Scios Says Two Deaths In Natrecor Trial Were Not Reported To FDA
Latest Natrecor News Increases Safety Concerns About J&J Heart Failure Drug The Scios unit of Johnson & Johnson (J&J) did not immediately report to the FDA two deaths from a clinical trial, or study,…
